Vanguard Group Inc Vera Therapeutics, Inc. Put Options Transaction History
Vanguard Group Inc
- $5.37 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$175 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$146 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$103 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$91 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$85.9 Million4.94% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $831M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...